Ian P. Stolerman - Publications

Affiliations: 
Psychological Medicine Institute of Psychiatry (IOP), King's College London 

95 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Ilott NE, Schneider T, Mill J, Schalkwyk L, Brolese G, Bizarro L, Stolerman IP, Dempster E, Asherson P. Long-term effects of gestational nicotine exposure and food-restriction on gene expression in the striatum of adolescent rats. Plos One. 9: e88896. PMID 24586432 DOI: 10.1371/Journal.Pone.0088896  0.681
2012 Schneider T, Bizarro L, Asherson PJ, Stolerman IP. Hyperactivity, increased nicotine consumption and impaired performance in the five-choice serial reaction time task in adolescent rats prenatally exposed to nicotine. Psychopharmacology. 223: 401-15. PMID 22562524 DOI: 10.1007/S00213-012-2728-7  0.726
2012 Shoaib M, Stolerman IP. The NMDA antagonist dizocilpine (M K801) attenuates tolerance to nicotine in rats. Journal of Psychopharmacology (Oxford, England). 10: 214-8. PMID 22302947 DOI: 10.1177/026988119601000306  0.57
2012 Garcha HS, Stolerman IP. Discriminative stimulus effects of the nicotine antagonist mecamylamine in rats. Journal of Psychopharmacology (Oxford, England). 7: 43-51. PMID 22290370 DOI: 10.1177/026988119300700108  0.522
2012 Quarta D, Naylor CG, Glennon JC, Stolerman IP. Serotonin antagonists in the five-choice serial reaction time task and their interactions with nicotine. Behavioural Pharmacology. 23: 143-52. PMID 22193593 DOI: 10.1097/Fbp.0B013E32834F9Fb4  0.534
2012 Reavill C, Stolerman IP. Interaction of nicotine with dopaminergic mechanisms assessed through drug discrimination and rotational behaviour in rats. Journal of Psychopharmacology (Oxford, England). 1: 264-73. PMID 22159140 DOI: 10.1177/026988118700100408  0.479
2011 Stolerman IP, Childs E, Ford MM, Grant KA. Role of training dose in drug discrimination: a review. Behavioural Pharmacology. 22: 415-29. PMID 21808191 DOI: 10.1097/Fbp.0B013E328349Ab37  0.349
2011 Hahn B, Shoaib M, Stolerman IP. Selective nicotinic receptor antagonists: effects on attention and nicotine-induced attentional enhancement. Psychopharmacology. 217: 75-82. PMID 21432025 DOI: 10.1007/S00213-011-2258-8  0.556
2011 Schneider T, Ilott N, Brolese G, Bizarro L, Asherson PJ, Stolerman IP. Prenatal exposure to nicotine impairs performance of the 5-choice serial reaction time task in adult rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 1114-25. PMID 21289608 DOI: 10.1038/Npp.2010.249  0.727
2010 Schneider T, Bizarro L, Asherson PJ, Stolerman IP. Gestational exposure to nicotine in drinking water: teratogenic effects and methodological issues. Behavioural Pharmacology. 21: 206-16. PMID 20480542 DOI: 10.1097/Fbp.0B013E32833A5Bb5  0.723
2009 Stolerman IP, Naylor CG, Mesdaghinia A, Morris HV. The duration of nicotine-induced attentional enhancement in the five-choice serial reaction time task: lack of long-lasting cognitive improvement. Behavioural Pharmacology. 20: 742-54. PMID 19901825 DOI: 10.1097/Fbp.0B013E328333B290  0.613
2009 Smith JW, Stolerman IP. Recognising nicotine: the neurobiological basis of nicotine discrimination. Handbook of Experimental Pharmacology. 295-333. PMID 19184654 DOI: 10.1007/978-3-540-69248-5_11  0.581
2009 Quarta D, Naylor CG, Barik J, Fernandes C, Wonnacott S, Stolerman IP. Drug discrimination and neurochemical studies in α7 null mutant mice: Tests for the role of nicotinic α7 receptors in dopamine release Psychopharmacology. 203: 399-410. PMID 18758759 DOI: 10.1007/S00213-008-1281-X  0.538
2007 Quarta D, Naylor CG, Morris HV, Patel S, Genn RF, Stolerman IP. Different effects of ionotropic and metabotropic glutamate receptor antagonists on attention and the attentional properties of nicotine. Neuropharmacology. 53: 421-30. PMID 17631918 DOI: 10.1016/J.Neuropharm.2007.05.023  0.541
2007 Semenova S, Stolerman IP, Markou A. Chronic nicotine administration improves attention while nicotine withdrawal induces performance deficits in the 5-choice serial reaction time task in rats. Pharmacology, Biochemistry, and Behavior. 87: 360-8. PMID 17582477 DOI: 10.1016/J.Pbb.2007.05.009  0.611
2007 Quarta D, Naylor CG, Stolerman IP. The serotonin 2C receptor agonist Ro-60-0175 attenuates effects of nicotine in the five-choice serial reaction time task and in drug discrimination. Psychopharmacology. 193: 391-402. PMID 17473916 DOI: 10.1007/S00213-007-0802-3  0.449
2007 Matta SG, Balfour DJ, Benowitz NL, Boyd RT, Buccafusco JJ, Caggiula AR, Craig CR, Collins AC, Damaj MI, Donny EC, Gardiner PS, Grady SR, Heberlein U, Leonard SS, Levin ED, ... ... Stolerman IP, et al. Guidelines on nicotine dose selection for in vivo research. Psychopharmacology. 190: 269-319. PMID 16896961 DOI: 10.1007/S00213-006-0441-0  0.54
2006 Hoyle E, Genn RF, Fernandes C, Stolerman I. Impaired performance of alpha7 nicotinic receptor knockout mice in the five-choice serial reaction time task Psychopharmacology. 189: 211-223. PMID 17019565 DOI: 10.1007/S00213-006-0549-2  0.513
2006 Patel S, Stolerman IP, Asherson P, Sluyter F. Attentional performance of C57BL/6 and DBA/2 mice in the 5-choice serial reaction time task. Behavioural Brain Research. 170: 197-203. PMID 16616787 DOI: 10.1016/J.Bbr.2006.02.019  0.301
2006 Childs E, Shoaib M, Stolerman IP. Cocaine self-administration in rats with histories of cocaine exposure and discrimination Psychopharmacology. 186: 168-176. PMID 16596400 DOI: 10.1007/S00213-006-0364-9  0.357
2006 Henningfield JE, Stolerman IP, Miczek KA. Nicotine psychopharmacology research: advancing science, public health, and global policy. Psychopharmacology. 184: 263-5. PMID 16463193 DOI: 10.1007/S00213-005-0297-8  0.369
2005 Naylor C, Quarta D, Fernandes C, Stolerman IP. Tolerance to nicotine in mice lacking alpha7 nicotinic receptors. Psychopharmacology. 180: 558-63. PMID 15723228 DOI: 10.1007/S00213-005-2187-5  0.501
2005 Hahn B, Stolerman IP. Modulation of nicotine-induced attentional enhancement in rats by adrenoceptor antagonists. Psychopharmacology. 177: 438-47. PMID 15252705 DOI: 10.1007/S00213-004-1969-5  0.563
2004 Stolerman IP, Chamberlain S, Bizarro L, Fernandes C, Schalkwyk LC. The role of nicotinic receptor α7 subunits in nicotine discrimination Neuropharmacology. 46: 363-371. PMID 14975691 DOI: 10.1016/J.Neuropharm.2003.10.002  0.715
2004 Bizarro L, Patel S, Stolerman IP. Comprehensive deficits in performance of an attentional task produced by co-administering alcohol and nicotine to rats. Drug and Alcohol Dependence. 72: 287-95. PMID 14643946 DOI: 10.1016/J.Drugalcdep.2003.08.004  0.698
2003 Bizarro L, Stolerman IP. Attentional effects of nicotine and amphetamine in rats at different levels of motivation. Psychopharmacology. 170: 271-277. PMID 12955304 DOI: 10.1007/S00213-003-1543-6  0.7
2003 Hahn B, Sharples CG, Wonnacott S, Shoaib M, Stolerman IP. Attentional effects of nicotinic agonists in rats. Neuropharmacology. 44: 1054-67. PMID 12763099 DOI: 10.1016/S0028-3908(03)00099-6  0.572
2003 Hahn B, Shoaib M, Stolerman IP. Involvement of the prefrontal cortex but not the dorsal hippocampus in the attention-enhancing effects of nicotine in rats. Psychopharmacology. 168: 271-9. PMID 12698230 DOI: 10.1007/S00213-003-1438-6  0.526
2003 Stolerman I. Hits and misses in nicotine psychopharmacology: a personal view of research over a period of 30 years. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 4: 389-94. PMID 12528675 DOI: 10.1080/1462220021000018489  0.391
2002 Hahn B, Shoaib M, Stolerman IP. Effects of dopamine receptor antagonists on nicotine-induced attentional enhancement Behavioural Pharmacology. 13: 621-632. PMID 12478212 DOI: 10.1097/00008877-200212000-00003  0.584
2002 Hahn B, Stolerman I. Nicotine-induced Attentional Enhancement in Rats: Effects of Chronic Exposure to Nicotine Neuropsychopharmacology. 27: 712-722. PMID 12431846 DOI: 10.1016/S0893-133X(02)00348-2  0.621
2002 Hahn B, Shoaib M, Stolerman IP. Nicotine-induced enhancement of attention in the five-choice serial reaction time task: The influence of task demands Psychopharmacology. 162: 129-137. PMID 12110990 DOI: 10.1007/s00213-002-1005-6  0.506
2002 Shoaib M, Gommans J, Morley A, Stolerman IP, Grailhe R, Changeux JP. The role of nicotinic receptor beta-2 subunits in nicotine discrimination and conditioned taste aversion. Neuropharmacology. 42: 530-9. PMID 11955523 DOI: 10.1016/S0028-3908(01)00194-0  0.553
2002 Stolerman IP. Drug stimulus generalization and Gossop's 'Web of dependence'. Addiction. 97: 152-154. PMID 11860386 DOI: 10.1046/J.1360-0443.2002.00009.X  0.302
2001 Stolerman IP, Olufsen K. Generalisation of ethanol with drug mixtures containing a positive modulator of the GABAA receptor and an NMDA antagonist Neuropharmacology. 40: 123-130. PMID 11077078 DOI: 10.1016/S0028-3908(00)00100-3  0.365
2000 Stolerman IP, Olufsen KS. Influence of training history on ethanol discrimination in rats. Behavioural Pharmacology. 11: 603-612. PMID 11198131 DOI: 10.1097/00008877-200011000-00007  0.357
2000 Gommans J, Stolerman IP, Shoaib M. Antagonism of the discriminative and aversive stimulus properties of nicotine in C57BL/6J mice Neuropharmacology. 39: 2840-2847. PMID 11044754 DOI: 10.1016/S0028-3908(00)00130-1  0.584
2000 Shoaib M, Zubaran C, Stolerman IP. Antagonism of stimulus properties of nicotine by dihydro-β-erythroidine (DHβE) in rats Psychopharmacology. 149: 140-146. PMID 10805608 DOI: 10.1007/S002139900348  0.622
2000 Stolerman IP, Mirza NR, Hahn B, Shoaib M. Nicotine in an animal model of attention. European Journal of Pharmacology. 393: 147-154. PMID 10771008 DOI: 10.1016/S0014-2999(99)00886-9  0.575
2000 Mirza NR, Stolerman IP. The role of nicotinic and muscarinic acetylcholine receptors in attention. Psychopharmacology. 148: 243-50. PMID 10755737 DOI: 10.1007/S002130050048  0.528
2000 Stolerman IP. Nicotine dependence: Concepts from animal experiments European Neuropsychopharmacology. 10: 118. DOI: 10.1016/S0924-977X(00)80013-9  0.513
1999 Stolerman IP, Mariathasan EA, White JA. Influencing the specificity of drug mixture discriminations by varying the training procedure. Behavioural Pharmacology. 10: 657-64. PMID 10780507 DOI: 10.1097/00008877-199911000-00012  0.416
1999 Mariathasan EA, Stolerman IP, White JA. Influence of training paradigm on specificity of drug mixture discriminations. Pharmacology, Biochemistry, and Behavior. 64: 409-13. PMID 10515322 DOI: 10.1016/S0091-3057(99)00088-X  0.455
1999 Stolerman IP, Mariathasan EA, White JA, Olufsen KS. Drug mixtures and ethanol as compound internal stimuli. Pharmacology, Biochemistry, and Behavior. 64: 221-8. PMID 10515295 DOI: 10.1016/S0091-3057(99)00087-8  0.357
1999 Zubaran C, Shoaib M, Stolerman IP, Pablo J, Mash DC. Noribogaine generalization to the ibogaine Stimulus: Correlation with noribogaine concentration in rat brain Neuropsychopharmacology. 21: 119-126. PMID 10379526 DOI: 10.1016/S0893-133X(99)00003-2  0.354
1999 Shoaib M, Stolerman IP. Plasma nicotine and cotinine levels following intravenous nicotine self- administration in rats Psychopharmacology. 143: 318-321. PMID 10353437 DOI: 10.1007/S002130050954  0.563
1999 Mariathasan EA, Stolerman IP, White JA. AND and AND-OR drug mixture discriminations in rats: generalization to single drugs and drug mixtures. Psychopharmacology. 143: 54-63. PMID 10227080 DOI: 10.1007/S002130050919  0.442
1999 Stolerman IP, Naylor C, Elmer GI, Goldberg SR. Discrimination and self-administration of nicotine by inbred strains of mice Psychopharmacology. 141: 297-306. PMID 10027511 DOI: 10.1007/S002130050837  0.522
1999 Kanýt L, Stolerman IP, Chandler CJ, Saigusa T, Pöğün S. Influence of sex and female hormones on nicotine-induced changes in locomotor activity in rats. Pharmacology, Biochemistry, and Behavior. 62: 179-87. PMID 9972862 DOI: 10.1016/S0091-3057(98)00140-3  0.459
1999 Stolerman IP, Hahn B, Mariathasan EA. Occasion Setting In Drug Discrimination: Using Nicotine To Signal The Appropriate Response To Midazolam Behavioural Pharmacology. 10. DOI: 10.1097/00008877-199908001-00227  0.468
1998 Mirza NR, Stolerman IP. Nicotine enhances sustained attention in the rat under specific task conditions. Psychopharmacology. 138: 266-74. PMID 9725748 DOI: 10.1007/S002130050671  0.578
1997 Stolerman IP, Chandler CJ, Garcha HS, Newton JM. Selective antagonism of behavioural effects of nicotine by dihydro-beta-erythroidine in rats. Psychopharmacology. 129: 390-7. PMID 9085409 DOI: 10.1007/s002130050205  0.455
1997 Chandler CJ, Stolerman IP. Discriminative stimulus properties of the nicotinic agonist cytisine. Psychopharmacology. 129: 257-64. PMID 9084064 DOI: 10.1007/s002130050188  0.536
1997 Mariathasan EA, Stolerman IP, White JA. Antagonism of AND and AND-OR drug mixture discriminations in rats. Drug and Alcohol Dependence. 44: 31-4. PMID 9031817 DOI: 10.1016/S0376-8716(96)01318-X  0.501
1996 Mariathasan EA, White JW, Stolerman IP. Training dose as a decisive factor for discrimination of a drug mixture in rats. Behavioural Pharmacology. 7: 364-372. PMID 11224430 DOI: 10.1097/00008877-199608000-00008  0.406
1996 Shoaib M, Stolerman IP. Brain sites mediating the discriminative stimulus effects of nicotine in rats Behavioural Brain Research. 78: 183-188. PMID 8864050 DOI: 10.1016/0166-4328(95)00245-6  0.615
1996 White JA, Stolerman IP. Reversal of overshadowing in a drug mixture discrimination in rats. Psychopharmacology. 123: 46-54. PMID 8741954 DOI: 10.1007/BF02246280  0.435
1996 Mirza NR, Pei Q, Stolerman IP, Zetterström TS. The nicotinic receptor agonists (-)-nicotine and isoarecolone differ in their effects on dopamine release in the nucleus accumbens. European Journal of Pharmacology. 295: 207-10. PMID 8720585 DOI: 10.1016/0014-2999(95)00749-0  0.522
1995 Whiteaker P, Garcha HS, Wonnacott S, Stolerman IP. Locomotor activation and dopamine release produced by nicotine and isoarecolone in rats British Journal of Pharmacology. 116: 2097-2105. PMID 8640351 DOI: 10.1111/J.1476-5381.1995.Tb16417.X  0.547
1995 Stolerman IP, Mirza NR, Shoaib M. Nicotine psychopharmacology: Addiction, cognition and neuroadaptation Medicinal Research Reviews. 15: 47-72. PMID 7898169 DOI: 10.1002/Med.2610150105  0.465
1995 Stolerman IP, Jarvis MJ. The scientific case that nicotine is addictive. Psychopharmacology. 117: 2-10; discussion 14-. PMID 7724697 DOI: 10.1007/BF02245088  0.469
1995 Stolerman IP, Garcha HS, Mirza NR. Dissociations between the locomotor stimulant and depressant effects of nicotinic agonists in rats. Psychopharmacology. 117: 430-7. PMID 7604144 DOI: 10.1007/Bf02246215  0.597
1994 White JW, Stolerman IP. Antagonism of a nicotine plus midazolam discriminative cue in rats. Behavioural Pharmacology. 5: 351-355. PMID 11224285 DOI: 10.1097/00008877-199406000-00013  0.543
1994 Shoaib M, Benwell ME, Akbar MT, Stolerman IP, Balfour DJ. Behavioural and neurochemical adaptations to nicotine in rats: influence of NMDA antagonists. British Journal of Pharmacology. 111: 1073-80. PMID 8032593 DOI: 10.1111/J.1476-5381.1994.Tb14854.X  0.559
1994 Shoaib M, Stolerman IP. Locomotor activity after nicotine infusions into the fourth ventricle of rats Pharmacology, Biochemistry and Behavior. 48: 749-754. PMID 7938131 DOI: 10.1016/0091-3057(94)90342-5  0.571
1994 Shoaib M, Stolerman IP, Kumar RC. Nicotine-induced place preferences following prior nicotine exposure in rats Psychopharmacology. 113: 445-452. PMID 7862857 DOI: 10.1007/Bf02245221  0.562
1993 Garcha HS, Thomas P, Spivak CE, Wonnacott S, Stolerman IP. Behavioural and ligand-binding studies in rats with 1-acetyl-4-methylpiperazine, a novel nicotinic agonist Psychopharmacology. 110: 347-354. PMID 7831430 DOI: 10.1007/Bf02251292  0.572
1992 Shoaib M, Stolerman IP. MK801 attenuates behavioural adaptation to chronic nicotine administration in rats British Journal of Pharmacology. 105: 514-515. PMID 1628139 DOI: 10.1111/J.1476-5381.1992.Tb09010.X  0.536
1992 Stolerman I. Drugs of abuse: behavioural principles, methods and terms Trends in Pharmacological Sciences. 13: 170-176. PMID 1604709 DOI: 10.1016/0165-6147(92)90059-F  0.323
1991 Stolerman IP. Behavioural pharmacology of nicotine: multiple mechanisms Addiction. 86: 533-536. PMID 1650269 DOI: 10.1111/J.1360-0443.1991.Tb01803.X  0.576
1991 Stolerman IP, Shoaib M. The neurobiology of tobacco addiction Trends in Pharmacological Sciences. 12: 467-473. DOI: 10.1016/0165-6147(91)90638-9  0.527
1990 Stolerman IP, Reavill C. Primary cholinergic and indirect dopaminergic mediation of behavioural effects of nicotine. Progress in Brain Research. 79: 227-37. PMID 2573911 DOI: 10.1016/S0079-6123(08)62482-6  0.46
1990 Reavill C, Stolerman IP. Locomotor activity in rats after administration of nicotinic agonists intracerebrally. British Journal of Pharmacology. 99: 273-8. PMID 2328395 DOI: 10.1111/J.1476-5381.1990.Tb14693.X  0.577
1990 Reavill C, Waters JA, Stolerman IP, Garcha HS. Behavioural effects of the nicotinic agonists N-(3-pyridylmethyl)pyrrolidine and isoarecolone in rats Psychopharmacology. 102: 521-528. PMID 2096409 DOI: 10.1007/Bf02247135  0.589
1989 Goldberg SR, Risner ME, Stolerman IP, Reavill C, Garcha HS. Nicotine and some related compounds: effects on schedule-controlled behaviour and discriminative properties in rats. Psychopharmacology. 97: 295-302. PMID 2497478 DOI: 10.1007/Bf00439441  0.514
1989 Stolerman IP. Discriminative stimulus effects of nicotine in rats trained under different schedules of reinforcement. Psychopharmacology. 97: 131-8. PMID 2496419 DOI: 10.1007/BF00443427  0.424
1988 Reavill C, Jenner P, Kumar R, Stolerman IP. High affinity binding of [3H] (-)-nicotine to rat brain membranes and its inhibition by analogues of nicotine. Neuropharmacology. 27: 235-41. PMID 3374769 DOI: 10.1016/0028-3908(88)90039-1  0.515
1988 Stolerman IP, Kumar R, Reavill C. Discriminative stimulus effects of cholinergic agonists and the actions of their antagonists. Psychopharmacology Series. 4: 32-43. PMID 3293044 DOI: 10.1007/978-3-642-73223-2_3  0.587
1988 Stolerman I. Behavioural Anylisis of Addiction: what future does it have? Addiction. 83: 991-993. PMID 3224195 DOI: 10.1111/J.1360-0443.1988.Tb00521.X  0.312
1988 Stolerman IP. Characterization of central nicotinic receptors by studies on the nicotine cue and conditioned taste aversion in rats. Pharmacology, Biochemistry, and Behavior. 30: 235-42. PMID 3174748 DOI: 10.1016/0091-3057(88)90451-0  0.527
1988 Durcan MJ, Garcha HS, Stolerman IP. Conditioned taste aversions produced by nicotine in Roman High and Low Avoidance strains of rats. Psychopharmacology. 94: 532-5. PMID 3131799 DOI: 10.1007/BF00212850  0.313
1987 Stolerman IP, Rauch RJ, Norris EA. Discriminative stimulus effects of a nicotine-midazolam mixture in rats. Psychopharmacology. 93: 250-6. PMID 3122258 DOI: 10.1007/BF00179943  0.412
1987 Kumar R, Reavill C, Stolerman IP. Nicotine cue in rats: effects of central administration of ganglion-blocking drugs. British Journal of Pharmacology. 90: 239-46. PMID 2880625 DOI: 10.1111/J.1476-5381.1987.Tb16845.X  0.603
1986 Reavill C, Stolerman IP, Kumar R, Garcha HS. Chlorisondamine blocks acquisition of the conditioned taste aversion produced by (-)-nicotine. Neuropharmacology. 25: 1067-9. PMID 3774129 DOI: 10.1016/0028-3908(86)90204-2  0.554
1986 Stolerman IP, Garcha HS, Rose IC. Midazolam cue in rats: effects of Ro 15-1788 and picrotoxin. Psychopharmacology. 89: 183-8. PMID 3014590 DOI: 10.1007/BF00310626  0.33
1985 Garcha HS, Rose IC, Stolerman IP. Midazolam cue in rats: generalization tests with anxiolytic and other drugs. Psychopharmacology. 87: 233-7. PMID 2864715 DOI: 10.1007/BF00431814  0.336
1984 Pratt JA, Stolerman IP. Pharmacologically specific pretreatment effects on apomorphine-mediated conditioned taste aversions in rats. Pharmacology, Biochemistry, and Behavior. 20: 507-11. PMID 6728868 DOI: 10.1016/0091-3057(84)90296-X  0.309
1984 Stolerman IP, Garcha HS, Pratt JA, Kumar R. Role of training dose in discrimination of nicotine and related compounds by rats. Psychopharmacology. 84: 413-9. PMID 6440189 DOI: 10.1007/Bf00555223  0.564
1983 Pratt JA, Stolerman IP, Garcha HS, Giardini V, Feyerabend C. Discriminative stimulus properties of nicotine: further evidence for mediation at a cholinergic receptor. Psychopharmacology. 81: 54-60. PMID 6415731 DOI: 10.1007/Bf00439274  0.554
1983 Stolerman IP, Pratt JA, Garcha HS, Giardini V, Kumar R. Nicotine cue in rats analysed with drugs acting on cholinergic and 5-hydroxytryptamine mechanisms. Neuropharmacology. 22: 1029-37. PMID 6138726 DOI: 10.1016/0028-3908(83)90021-7  0.58
1983 Kumar R, Pratt JA, Stolerman IP. Characteristics of conditioned taste aversion produced by nicotine in rats. British Journal of Pharmacology. 79: 245-53. PMID 6135477 DOI: 10.1111/J.1476-5381.1983.Tb10518.X  0.51
1976 Goldfarb T, Gritz ER, Jarvik ME, Stolerman IP. Reactions to cigarettes as a function of nicotine and "tar". Clinical Pharmacology and Therapeutics. 19: 767-72. PMID 5215 DOI: 10.1002/cpt1976196767  0.413
1974 Stolerman IP, Bunker P, Jarvik ME. Nicotine tolerance in rats; role of dose and dose interval. Psychopharmacologia. 34: 317-24. PMID 4812657 DOI: 10.1007/BF00422555  0.351
1973 Stolerman IP, Fink R, Jarvik ME. Acute and chronic tolerance to nicotine measured by activity in rats. Psychopharmacologia. 30: 329-42. PMID 4722204 DOI: 10.1007/BF00429192  0.363
1973 Stolerman IP, Goldfarb T, Fink R, Jarvik ME. Influencing cigarette smoking with nicotine antagonists. Psychopharmacologia. 28: 247-59. PMID 4691000 DOI: 10.1007/BF00429305  0.325
Show low-probability matches.